Alpha Centric Advisors LLC Charles River Laboratories International, Inc. Transaction History
Alpha Centric Advisors LLC
- $97.4 Million
- Q4 2024
A detailed history of Alpha Centric Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 1,474 shares of CRL stock, worth $225,153. This represents 0.28% of its overall portfolio holdings.
Number of Shares
1,474Holding current value
$225,153% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
607Shares Held
53.6MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA5.81MShares$888 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$777 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$655 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$365 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$350 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.77B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...